Advertisement
UK markets close in 7 minutes
  • FTSE 100

    8,040.61
    +16.74 (+0.21%)
     
  • FTSE 250

    19,757.90
    +158.51 (+0.81%)
     
  • AIM

    755.04
    +5.86 (+0.78%)
     
  • GBP/EUR

    1.1627
    +0.0038 (+0.33%)
     
  • GBP/USD

    1.2440
    +0.0090 (+0.73%)
     
  • Bitcoin GBP

    53,587.14
    +661.74 (+1.25%)
     
  • CMC Crypto 200

    1,437.67
    +22.91 (+1.62%)
     
  • S&P 500

    5,066.80
    +56.20 (+1.12%)
     
  • DOW

    38,465.04
    +225.06 (+0.59%)
     
  • CRUDE OIL

    82.68
    +0.78 (+0.95%)
     
  • GOLD FUTURES

    2,332.80
    -13.60 (-0.58%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     
  • DAX

    18,112.51
    +251.71 (+1.41%)
     
  • CAC 40

    8,098.11
    +57.75 (+0.72%)
     

BUZZ-Nanoco: cuts revenue forecast

** Nanoco biggest FTSE Small Cap loser after the nanotechnology co cuts revenue forecast due to lower royalty payments from Dow Chemical (Hanover: DCH1.HA - news)

** Co says an agreement allowing Dow to licence its cadmium-free quantum dot technology has been modified, resulting in lower royalty rates and no earn-out income for Nanoco

** Co partnered with Dow Chemical in 2014

** Prior to the announcement, analysts expected co's FY revenue at 4.99 mln stg vs 2.03 mln stg last yr

** Liberum analysts say change is expected to reduce Nanoco's FY16 sales levels below Liberum's 5 mln stg forecast and could also hurt their forecast for FY17

ADVERTISEMENT

** The analysts add Nanoco is potentially a more appealing M&A target than it was under an exclusive supply relationship with Dow

** Stock down 8.7 pct (RM (LSE: RM.L - news) : noor.hussain.thomsonreuters.com@reuters.net)